UK organisations allocate £9m to r&d

Published: 13-Sep-2011
Research & Development Finance

For projects focused on nanoscale technology enabled solutions for the healthcare sector


The UK’s Technology Strategy Board, in partnership with the Engineering and Physical Sciences Research Council (EPSRC), have jointly allocated up to £9m to support business-led collaborative research projects focused on nanoscale technology enabled solutions for the healthcare sector, specifically in the areas of diagnostics and targeted therapeutics.

The Technology Strategy Board will invest up to £3m to support involvement by businesses, while EPSRC will invest up to £6m to support participation by academic institutions.

The organisations are looking for projects where nanoscale technologies are at the heart of the innovation.

The Nanoscale Technology Enabled Healthcare competition opens on 1 November and applications must be received by 13 December.

  • Companies:
  • EPSRC Engineering and Physical Sciences Research Council
  • Innovate UK
See more

You may also like

Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Read more
Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's biopharmaceutical presence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria
Research & Development

Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture

In collaboration with CPI, Intellegens has secured a grant from Innovate UK to fund a two year project to augment technology that will assist productivity and yields of oligonucleotide therapeutic manufacture
Finance

Start-up receives Innovate UK funding for intraocular lens implant

Cataract is the most common cause of treatable blindness worldwide and is treated with surgery, however there is risk of postoperative inflammation
Finance

Innovate UK funds biologics manufacturing consortium

This project aims to address challenges faced in the pharmaceutical industry by increasing flexibility and sustainability, and reducing batch failures
Finance

Ingenza receives grant from Eureka and Innovate UK

The grant will support Ingenza as it aims to build a commercially viable <i>P. putida</i> bio-manufacturing pipeline
Research & Development

Turntable-like catalytic reactor wins Innovate funding

The Spinning Disc Mesh Reactor developed by Bath chemical engineers aims to make pharmaceutical production safer and more sustainable
Ingredients

Research partnership removes bottleneck from AAV development

CPI, Cobra Biologics and GE Healthcare Life Sciences have developed a scalable, cost-effective purification process for adeno-associated viruses
Subscribe now